Rchr
J-GLOBAL ID:201801001837136070   Update date: Oct. 16, 2024

Dohi Tomotaka

Dohi Tomotaka
Research field  (1): Cardiology
Research keywords  (5): 循環器病予防 ,  General cardiology ,  Intravascular imaging ,  Atherosclerosis ,  Coronary artery disease
Research theme for competitive and other funds  (1):
  • 2016 - 2019 Association between coronary plaque characteristics and sleep disordered breathing
Papers (225):
  • Yui O Nozaki, Shinichiro Fujimoto, Daigo Takahashi, Ayako Kudo, Yuko O Kawaguchi, Hideyuki Sato, Hikaru Kudo, Kazuhisa Takamura, Makoto Hiki, Tomotaka Dohi, et al. Additional prognostic impact of plaque characterization with on-site CT-derived fractional flow reserve in coronary CT angiography. Journal of cardiology. 2024. 84. 5. 336-341
  • Yuichi Chikata, Hiroshi Iwata, Katsutoshi Miyosawa, Ryo Naito, Takuma Koike, Soshi Moriya, Hidetoshi Yasuda, Takehiro Funamizu, Shinichiro Doi, Hirohisa Endo, et al. Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention. Cardiovascular diabetology. 2024. 23. 1. 114-114
  • Yui Okada Nozaki, Shoichiro Yatsu, Manabu Ogita, Hideki Wada, Daigo Takahashi, Ryota Nishio, Kentaro Yasuda, Mitsuhiro Takeuchi, Norihito Takahashi, Taketo Sonoda, et al. Outcome after primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction complicated by cardiogenic shock. Journal of cardiology. 2024
  • Tatsuya Fukase, Tomotaka Dohi, Ryota Nishio, Mitsuhiro Takeuchi, Norihito Takahashi, Yuichi Chikata, Hirohisa Endo, Shinichiro Doi, Hiroki Nishiyama, Iwao Okai, et al. Long-Term Impact of Renin-Angiotensin System Inhibitors for Secondary Prevention in Patients with Chronic Kidney Disease Who Underwent Percutaneous Coronary Intervention. Kidney diseases (Basel, Switzerland). 2024. 10. 1. 39-50
  • Tatsuya Fukase, Shinichiro Doi, Tomotaka Dohi, Takuma Koike, Ryota Nishio, Hidetoshi Yasuda, Mitsuhiro Takeuchi, Norihito Takahashi, Yuichi Chikata, Hirohisa Endo, et al. Impact of Low-Dose Prasugrel on Platelet Reactivity in Chronic Phase of Post-Percutaneous Coronary Intervention (CHAPERON): a Prospective Cohort Study. Cardiovascular drugs and therapy. 2023
more...
MISC (167):
  • 深瀬達也, 土肥智貴, 西尾亮太, 竹内充裕, 高橋徳仁, 近田雄一, 遠藤裕久, 土井信一郎, 西山大樹, 岡井巌, et al. 経皮的冠動脈形成術が施行された患者における長期予後に関するアポリポ蛋白A1と慢性腎臓病の複合的影響. 日本動脈硬化学会総会・学術集会プログラム・抄録集(Web). 2023. 55th
  • Ryota Nishio, Dohi Tomotaka, Tatsuya Fukase, Mitsuhiro Takeuchi, Norihito Takahashi, Endo Hirohisa, Shinichiro Doi, Iwao Okai, Hiroshi Iwata, Shinya Okazaki, et al. The Estimated Appendicular Skeletal Muscle Mass Predicts Adverse Outcomes in Patients Under 65 Years With Coronary Artery Disease. CIRCULATION. 2022. 146
  • Tatsuya Fukase, Dohi Tomotaka, Shinichiro Fujimoto, Yui Nozaki, Ryota Nishio, Ayako Kudo, Mitsuhiro Takeuchi, Norihito Takahashi, Yuichi Chikata, Endo Hirohisa, et al. Relationship Between Coronary HIPs on Non-Contrast T1-WI by CMR and Vulnerable Plaque Features by NIRS-IVUS. CIRCULATION. 2022. 146
  • Tatsuya Fukase, Shinichiro Doi, Dohi Tomotaka, Ryota Nishio, Norihito Takahashi, Yuichi Chikata, Endo Hirohisa, Hiroki Nishiyama, Iwao Okai, Hiroshi Iwata, et al. Therapeutic Window of Low-Dose Prasugrel for Platelet Reactivity in the Chronic Phase of Post-Percutaneous Coronary Intervention: The Chaperon Study. CIRCULATION. 2022. 146
  • Ryota Nishio, Tomotaka Dohi, Tatsuya Fukase, Mitsuhiro Takeuchi, Norihito Takahashi, Hirohisa Endo, Shinichiro Doi, Iwao Okai, Hiroshi Iwata, Shinya Okazaki, et al. THE NOVEL SIMPLE EQUATION FOR ESTIMATING APPENDICULAR SKELETAL MUSCLE MASS PREDICTED ADVERSE OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2022. 79. 9. 1608-1608
more...
Professional career (1):
  • 医学博士 (順天堂大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page